Prevalence of HPV infection among men: A systematic review of the literature

Journal of Infectious Diseases

Volumn 194, Issue 8, 2006, Pages 1044-1057

  Dunne, Eileen F ^a,b   Nielson, Carrie M ^c   Stone, Katherine M ^b   Markowitz, Lauri E ^a   Giuliano, Anna R ^b  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b University of Arizona ^*  (United States)

^c H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS DNA;

ANATOMY; CONDYLOMA; DNA DETERMINATION; HETEROSEXUALITY; HIGH RISK POPULATION; HUMAN; MALE; NONHUMAN; PREVALENCE; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SAMPLING; SEROPREVALENCE; SEXUAL BEHAVIOR; SEXUALLY TRANSMITTED DISEASE; SYSTEMATIC REVIEW; TECHNIQUE; UNITED STATES; VIRUS TRANSMISSION; VIRUS TYPING; WART VIRUS;

DNA, VIRAL; HETEROSEXUALITY; HUMANS; MALE; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; RISK FACTORS; SEROEPIDEMIOLOGIC STUDIES; SEXUALLY TRANSMITTED DISEASES;

EID: 33749631190     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/507432     Document Type: Review

References (69)

1. Cates W Jr, American Social Health Association. Estimates of the incidence and prevalence of sexually transmitted diseases in the United States. Panel. Sex Transm Dis 1999; 26(Suppl 1):S2-7.
2. Weinstock H, Berman S, Cates W Jr. Sexually transmitted diseases among American youth: incidence and prevalence estimates, 2000. Perspect Sex Reprod Health 2004; 36:6-10.
3. Villa LL, Costa RL, Petta CA, et al. Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial. Lancet Oncol 2005; 6:271-8.
4. Harper DM, Franco EL, Wheeler C, et al. Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomised controlled trial. GlaxoSmithKline HPV Vaccine Study Group. Lancet 2004; 364:1757-65.
5. Aynaud O, Poveda JD, Huynh B, Guillemotonia A, Barrasso R. Frequency of herpes simplex virus, cytomegalovirus and human papillomavirus DNA in semen. Int J STD AIDS 2002; 13:547-50.
6. Baken LA, Koutsky LA, Kuypers J, et al. Genital human papillomavirus infection among male and female sex partners: prevalence and type-specific concordance. J Infect Dis 1995; 171:429-32.
7. Baldwin SB, Wallace DR, Papenfuss MR, et al. Human papillomavirus infection in men attending a sexually transmitted disease clinic. J Infect Dis 2003; 187:1064-70.
8. Bleeker MC, Hogewoning CJ, Van Den Brule AJ, et al. Penile lesions and human papillomavirus in male sexual partners of women with cervical intraepithelial neoplasia. J Am Acad Dermatol 2002; 47:351-7.
9. Castellsagué X, Ghaffari A, Daniel RW, Bosch FX, Muñoz N, Shah KV. Prevalence of penile human papillomavirus DNA in husbands of women with and without cervical neoplasia: a study in Spain and Colombia. J Infect Dis 1997; 176:353-61.
10. Della Torre G, Donghi R, de Campos Lima PO, et al. Human papillomavirus genomes in male urethral cells. Am J Pathol 1992; 141:1181-6.
11. Fife KH, Coplan PM, Jansen KU, et al. Poor sensitivity of polymerase chain reaction assays of genital skin swabs and urine to detect HPV 6 and 11 DNA in men. Sex Transm Dis 2003; 30:246-8.
12. Forslund O, Hansson BG, Rymark P, Bjerre B. Human papillomavirus DNA in urine samples compared with that in simultaneously collected urethra and cervix samples. J Clin Microbiol 1993; 31:1975-9.
13. Franceschi S, Castellsague X, Dal Maso L, et al. Prevalence and determinants of human papillomavirus genital infection in men. Br J Cancer 2002; 86:705-11.
14. Geddy PM, Wells M, Lacey CJ. Lack of detection of human papillomavirus DNA in male urine samples. Genitourin Med 1993; 69:276-9.
15. Green J, Monteiro E, Bolton VN, Sanders P, Gibson PE. Detection of human papillomavirus DNA by PCR in semen from patients with and without penile warts. Genitourin Med 1991; 67:207-10.
16. Hippelainen M, Syrjanen S, Hippelainen M, et al. Prevalence and risk factors of genital human papillomavirus (HPV) infections in healthy males: a study on Finnish conscripts. Sex Transm Dis 1993; 20:321-8.
17. Inoue M, Nakazawa A, Fujita M, Tanizawa O. Human papillomavirus (HPV) type 16 in semen of partners of women with HPV infection. Lancet 1992; 339:1114-5.
18. Kataoka A, Claesson U, Hansson BG, Eriksson M, Lindh E. Human papillomavirus infection of the male diagnosed by Southern-blot hybridization and polymerase chain reaction: comparison between urethra samples and penile biopsy samples. J Med Virol 1991; 33:159-64.
19. Kjaer SK, Munk C, Winther JF, Jorgensen HO, Meijer CJ, van den Brule AJ. Acquisition and persistence of human papillomavirus infection in younger men: a prospective follow-up study among Danish soldiers. Cancer Epidemiol Biomarkers Prev 2005; 14:1528-33.
20. Kyo S, Inoue M, Koyama M, et al. Detection of high-risk human papillomavirus in the cervix and semen of sex partners. J Infect Dis 1994; 170:682-5.
21. Lai YM, Lee JF, Huang HY, et al. The effect of human papillomavirus infection on sperm cell motility. Fertil Steril 1997; 67:1152-5.
22. Lazcano-Ponce E, Herrero R, Munoz N, et al. High prevalence of human papillomavirus infection in Mexican males: comparative study of penile-urethral swabs and urine samples. Sex Transm Dis 2001; 28:277-80.
23. Nicolau SM, Camargo CG, Stavale JN, et al. Human papillomavirus DNA detection in male sexual partners of women with genital human papillomavirus infection. Urology 2005; 65:251-5.
24. Olatunbosun O, Deneer H, Pierson R. Human papillomavirus DNA detection in sperm using polymerase chain reaction. Obstet Gynecol 2001; 97:357-60.
25. Rintala MAM, Pöllanen PP, Nikkanen VP, Grénman SE, Syrjänen SM. Human papillomavirus DNA is found in the vas deferens. J Infect Dis 2002; 185:1664-7.
26. Shin H-R, Franceschi S, Vaccarella S, et al. Prevalence and determinants of genital infection with papillomavirus, in female and male university students in Busan, South Korea. J Infect Dis 2004; 190:468-76.
27. Svare EI, Kjaer SK, Worm AM, Osterlind A, Meijer CJ, van den Brule AJ. Risk factors for genital HPV DNA in men resemble those found in women: a study of male attendees at a Danish STD clinic. Sex Transm Infect 2002; 78:215-8.
28. Takahashi S, Shimizu T, Takeyama K, et al. Detection of human papillomavirus DNA on the external genitalia of healthy men and male patients with urethritis. Sex Transm Dis 2003; 30:629-33.
29. Tanaka H, Karube A, Kodama H, Fukuda J, Tanaka T. Mass screening for human papillomavirus type 16 infection in infertile couples. J Reprod Med 2000; 45:907-11.
30. van der Snoek EM, Niesters HG, Mulder PG, van Doornum GJ, Osterhaus AD, van der Meijden WI. Human papillomavirus infection in men who have sex with men participating in a Dutch gay-cohort study. Sex Transm Dis 2003; 30:639-44.
31. Van Doornum GJ, Prins M, Juffermans LH, et al. Regional distribution and incidence of human papillomavirus infections among heterosexual men and women with multiple sexual partners: a prospective study. Genitourin Med 1994; 70:240-6.
32. Weaver BA, Feng Q, Holmes KK, et al. Evaluation of genital sites and sampling techniques for detection of human papillomavirus DNA in men. J Infect Dis 2004; 189:677-85.
33. Wikstrom A, Lidbrink P, Johansson B, von Krogh G. Penile human papillomavirus carriage among men attending Swedish STD clinics. Int J STD AIDS 1991; 2:105-9.
34. Wikstrom A, Popescu C, Forslund O. Asymptomatic penile HPV infection: a prospective study. Int J STD AIDS 2000; 11:80-4.
35. Astori G, Pipan C, Muffato G, Botta GA. Detection of HPV-DNA in semen, urine and urethral samples by dot blot and PCR. New Microbiol 1995; 18:143-9.
36. Hernandez BY, McDuffie K, Goodman MT, et al. Comparison of physician-and self-collected genital specimens for detection of human papillomavirus in men. J Clin Microbiol 2006; 44:513-17.
37. Hippelainen MI, Yliskoski M, Syrjanen S, et al. Low concordance of genital human papillomavirus (HPV) lesions and viral types in HPV-infected women and their male sexual partners. Sex Transm Dis 1994; 21:76-82.
38. Takahashi S, Takeyama K, Miyamoto S, et al. Incidence of sexually transmitted infections in asymptomatic healthy young Japanese men. J Infect Chemother 2005; 21:76-82.
39. Bleeker MCG, Hogewoning CJA, Berkhof J, et al. Concordance of specific human papillomavirus types in sex partners is more prevalent than would be expected by chance and is associated with increased viral loads. Clin Infect Dis 2005; 41:612-20.
40. Rosenblatt C, Lucon AM, Pereyra EA, Pinotti JA, Arap S, Ruiz CA. HPV prevalence among partners of women with cervical intraepithelial neoplasia. Int J Gynaecol Obstet 2004; 84:156-61.
41. Lajous M, Mueller N, Cruz-Valdez A, Aguilar LV, Franceschi S, Hernandez-Avila M. Determinants of prevalence, acquisition, and persistence of human papillomavirus in healthy Mexican military men. Cancer Epidemiol Biomarkers Prev 2005; 14:1710-6.
42. Aguilar LV, Lazcano-Ponce E, Vaccarella S, et al. Human papillomavirus in men: comparison of different genital sites. Sex Transm Infect 2006; 82:31-3.
43. Baldwin SB, Wallace DR, Papenfuss MR, Abrahamsen M, Vaught LC, Giuliano AR. Condom use and other factors affecting penile human papillomavirus detection in men attending a sexually transmitted disease clinic. Sex Transm Dis 2004; 31:601-7.
44. Castellsague X, Bosch FX, Munoz N, et al. Male circumcision, penile human papillomavirus infection, and cervical cancer in female partners. N Engl J Med 2002; 346:1105-12.
45. Burchell AN, Richardson H, Mahmud SM, et al. Modeling the sexual transmissibility of human papillomavirus infection using stochastic computer simulation and empirical data from a cohort study of young women in Montreal, Canada. Am J Epidemiol 2006; 163:534-43.
46. Carter JJ, Madeline MM, Shera K, et al. Human papillomavirus 16 and 18 L1 serology compared across anogenital cancer sites. Cancer Res 2001; 61:1934-40.
47. Carter JJ, Wipf GC, Hagensee ME, et al. Use of human papillomavirus type 6 capsids to detect antibodies in people with genital warts. J Infect Dis 1995; 172:11-8.
48. Eisemann C, Fisher SG, Gross G, Muller M, Gissmann L. Antibodies to human papillomavirus type 11 virus-like particles in sera of patients with genital warts and in control groups. J Gen Virol 1996; 77:1799-803.
49. Hagensee ME, Kiviat N, Critchlow CW, et al. Seroprevalence of human papillomavirus types 6 and 16 capsid antibodies in homosexual men. J Infect Dis 1997; 176:625-31.
50. Hisada M, Rabkin CS, Strickler HD, Wright WE, Christianson RE, van den Berg BJ. Human papillomavirus antibody and risk of prostate cancer. JAMA 2000; 283:340-1.
51. Slavinsky J III, Kissinger P, Burger L, Boley A, DiCarlo RP, Hagensee ME. Seroepidemiology of low and high oncogenic risk types of human papillomavirus in a predominantly male cohort of STD clinic patients. Int J STD AIDS 2001; 12:516-23.
52. Strickler HD, Kirk GD, Figueroa JP, et al. HPV 16 antibody prevalence in Jamaica and the United States reflects differences in cervical cancer rates. Int J Cancer 1999; 80:339-44.
53. Svare EI, Kjaer SK, Nonnenmacher B, et al. Seroreactivity to human papillomavirus type 16 virus-like particles is lower in high-risk men than in high-risk women. J Infect Dis 1997; 176:876-83.
54. Wideroff L, Schiffman M, Hubbert N, et al. Serum antibodies to HPV 16 virus-like particles are not associated with penile cancer in Chinese males. Viral Immunol 1996; 9:23-5.
55. Wikstrom A, Eklund C, Von Krogh G, Lidbrink P, Dillner J. Levels of immunoglobulin G antibodies against defined epitopes of the L1 and L2 capsid proteins of human papillomavirus type 6 are elevated in men with a history of condylomata acuminata. J Clin Microbiol 1992; 30:1795-800.
56. Wikstrom A, Eklund C, von Krogh G, Lidbrink P, Dillner J. Antibodies against human papillomavirus type 6 capsids are elevated in men with previous condylomas. APMIS 1997; 105:884-8.
57. Stone KM, Karem KL, Sternberg MR, et al. Seroprevalence of human papillomavirus type 16 infection in the United States. J Infect Dis 2002; 186:1396-402.
58. Thompson DL, Douglas JM Jr, Foster M, et al. Seroepidemiology of infection with human papillomavirus 16, in men and women attending sexually transmitted disease clinics in the United States. J Infect Dis 2004; 190:1563-74.
59. Kreimer AR, Alberg AJ, Viscidi R, Gillison ML. Gender differences in sexual biomarkers and behaviors associated with human papillomavirus-16, -18, and -33 seroprevalence. Sex Transm Dis 2004; 31:247-56.
60. Revzina NV, Diclemente RJ. Prevalence and incidence of human papillomavirus infection in women in the USA: a systematic review. Int J STD AIDS 2005; 16:528-37.
61. Carter JJ, Koutsky LA, Hughes JP, et al. Comparison of human papillomavirus types 16, 18, and 6 capsid antibody responses following incident infection. J Infect Dis 2000; 181:1911-9.
62. Kruger Kjaer S, Munk C, Winther JF, et al. Acquisition and persistence of human papillomavirus infection in younger men: a prospective follow-up study among Danish soldiers. Cancer Epidemiol Biomarkers Prev 2005; 14:1528-33.
63. Coursaget P. Serology for human papillomavirus. Salud Publica Mex 2003; 45(Suppl 3):S361-6.
64. Hamsikova E, Ludvikova V, Smahel M, Sapp M, Vonka V. Prevalence of antibodies to human papillomaviruses in the general population of the Czech Republic. Int J Cancer 1998; 77:689-94.
65. Karem KL, Poon AC, Bierl C, Nisenbaum R, Unger E. Optimization of a human papillomavirus-specific enzyme-linked immunosorbent assay. Clin Diagn Lab Immunol 2002; 9:577-82.
66. Wright TC, Shiffman M, Solomon D, et al. Interim guidance for the use of human papillomavirus DNA testing as an adjunct to cervical cytology for screening. Obstet Gynecol 2004; 103:304-9.
67. Saslow D, Runowicz CD, Solomon D, et al. American Cancer Society guideline for the early detection of cervical neoplasia and cancer. CA Cancer J Clin 2002; 52:342-62.
68. Krebs HB, Helmkamp BF. Does the treatment of genital condylomata in men decrease the treatment failure rate of cervical dysplasia in the female sexual partner? Obstet Gynecol 1990; 76:660-3.
69. Krebs HB, Helmkamp BF. Treatment failure of genital condylomata acuminata in women: role of the male sexual partner. Am J Obstet Gynecol 1991; 165:337-40.